In a clinical study on France broke the tragic news for one day, for a private research company Biotrial what happened more details are emerging. Biotrial is located in Rennes, it is a place of research occurs. January 15, a list of reference information for future trial participants are posted on local news websites France Breizh-info.com, including research objectives and processes are summarized, and referred to the lengthy drug safety research participation We will be faced with what.
For the record, this particular study group participants will receive € 1,900, including travel expenses. In return, they agreed to stay on for two weeks in Biotrial facilities located in Rennes, swallow a drug for 10 days, through expensive medical tests, and provide at least 40 blood samples.
At the same time, funding this test Portuguese pharmaceutical company Bial in a statement confirmed that the study tested the drug is an amide hydrolase (FAAH) inhibitor. FAAH can decompose in the brain is a so-called endocannabinoids enzymes, which inhibitor is considered a possible therapy against chronic pain.
The study was stopped immediately. Rennes University Hospital Center neurologist Gilles Edan said, all six patients taking the drug have been hospitalized, including one brain-dead, 4 people with varying degrees of neurological symptoms, another one is in the observation but no symptoms . MRI imaging revealed the presence of the patient brain "necrotizing and hemorrhagic depth damage."
Biotrial and Bial were not confirmed the authenticity of the site on Breizh-info.com share data. However, some details suggest that it is indeed available to consider the participation of healthy volunteers in this study information. List describes a study of the BIA 10-2474. This is a compound to be included in a trial to test the Bial. Some of this information potential therapeutic applications with French Minister of Health provided Marisol Touraine said at a news conference mentioned match.
Bolise Co., Ltd. http://www.chemicalspharm.com/
没有评论:
发表评论